Analyst Report: BG
1. EXECUTIVE SUMMARY
On July 29, 2026, shares of Bunge Global SA (NYSE: BG) plummeted -8.17% to close at $107.78 following the release of its Q2 2026 financial results. Although the company reported top- and bottom-line beats—delivering adjusted EPS of $2.00 (vs. $1.95 consensus) and net sales of $24.04 billion (+88.3% YoY post-Viterra consolidation)—and raised its full-year 2026 adjusted EPS guidance to $9.25–$9.75, the market reacted aggressively to underlying balance sheet and cash flow strains. Investor anxiety surged over a persistent operating cash flow deficit (-$1.13 billion in H1 2026 driven by a $2.24 billion inventory build), reduced second-half expectations for the Grain Merchandising and Milling segment, elevated full-year net interest expense guidance ($620 million–$660 million), and equity overhang fears following the expiration of Glencore’s post-merger share lockup. While Bunge's core oilseed processing operations remain exceptionally profitable, institutional investors used the earnings print to lock in profits after a 22%+ YTD rally, shifting focus toward cash conversion, integration debt, and working capital intensity.
2. THE CATALYST (CRITICAL)
Event Summary
The specific trigger for the -8.17% drop was the publication of Bunge Global SA’s Q2 2026 Earnings Release and Updated FY2026 Financial Outlook, submitted via SEC Form 8-K and discussed on the management earnings call on Wednesday morning, July 29, 2026.
- Earnings Release Date/Time: July 29, 2026, at 6:00 AM ET (Press Release / 8-K filing)
- Conference Call Date/Time: July 29, 2026, at 8:00 AM ET
- Sources: Bunge Global SA Q2 2026 SEC Form 8-K, Press Release, and Investor Presentation (July 29, 2026).
Key Reported Metrics vs. Consensus
| Metric | Q2 2026 Reported | Consensus Estimate | Surprise / YoY |
|---|---|---|---|
| Adjusted EPS | $2.00 | $1.95 | +$0.05 (+2.56% beat) / +52.7% YoY |
| GAAP Diluted EPS | $3.47 | N/A | +33.0% YoY (vs. $2.61 in Q2 2025) |
| Net Sales (Revenue) | $24.04 Billion | $22.35 Billion | +$1.69 Billion (+7.56% beat) / +88.3% YoY |
| Adjusted Segment EBIT | $796 Million | ~$710 Million | +113.4% YoY (vs. $373 Million in Q2 2025) |
| FY2026 Adj. EPS Guidance | $9.25 – $9.75 | $9.32 | Raised from $9.00 – $9.50 |
Why Did Shares Sell Off Despite the Headline Beat?
- Grain Merchandising Guidance Cut: Despite raising total EPS guidance, management downgraded second-half expectations for the Grain Merchandising and Milling segment. Farmers holding grain off the market, shifting global trade routes, and lower merchandising margins in Europe offset crush strength.
- Severe Operating Cash Flow Drain: Operating cash flow for H1 2026 remained negative at -$1.126 billion. A massive working capital build—including a $2.235 billion increase in inventories and $257 million in supplier advances post-Viterra integration—raised sharp liquidity and cash conversion questions.
- Glencore Share Lockup Expiration: Management confirmed during the call that the post-merger share lockup for former Viterra shareholder Glencore has expired. While management noted Glencore is "in no hurry", the loss of lockup protection creates a persistent secondary share overhang risk.
- Rising Cost Structure & Debt Burden: Net debt reached $15.21 billion post-Viterra. Full-year net interest expense was guided to $620 million–$660 million, while capital expenditures are trending toward the upper end of the $1.5 billion–$1.7 billion range.
3. COMPANY PROFILE
Core Business
Bunge Global SA (NYSE: BG) is one of the world’s "ABCD" agricultural commodity giants (alongside ADM, Cargill, and Louis Dreyfus). The company connects farmers to consumers by originating, storing, transporting, processing, and distributing oilseeds and grains. Its primary operations include Soybean Processing & Refining, Softseed Processing & Refining (canola, rapeseed, sunflower), Grain Merchandising & Milling, and Tropical Oils & Bioenergy Feedstocks.
Profile Snapshot
| Parameter | Value |
|---|---|
| Official Name | Bunge Global SA |
| Ticker | BG (NYSE) |
| Market Capitalization | ~$22.77 Billion (as of July 29, 2026 close) |
| Sector / Industry | Consumer Defensive / Farm Products (Agribusiness) |
| Primary Competitors | Archer-Daniels-Midland (ADM), Corteva (CTVA), Cargill (Private), Louis Dreyfus (Private) |
| 52-Week Range | $74.95 – $134.87 |
| Closing Price (July 29, 2026) | $107.78 (-8.17%) |
| YTD Performance | +22.4% (inclusive of July 29 pullback) |
4. DEEP DIVE ANALYSIS
Fundamentals: Overreaction or Justified Adjustment?
The -8.17% sell-off represents an overreaction to headline optics, but a justified recalibration of balance sheet risk:
- The Fundamental Strength: Core processing fundamentals are robust. Softseed EBIT surged nearly 18-fold YoY to $255 million (vs. $14 million in Q2 2025), while Soybean Processing EBIT rose 46% YoY to $445 million. North American crush margins benefit from strong domestic protein meal demand and U.S. Renewable Volume Obligations (RVO) under the Renewable Fuel Standard. Viterra run-rate cost synergies were raised from $250 million to $350 million annually.
- The Valuation Frictions: Working capital expansion ($15.46 billion in total inventory) has compressed trailing 12-month free cash flow margins into negative territory (-1.4%). With net margins near ~0.9% and interest expenses taking up $620M–$660M annually, investors are punishing the stock for cash burn despite strong accounting profits.
Q2 2026 Adjusted EBIT Breakdown by Segment: =================================================== Soybean Processing & Refining : $445M (+46.4% YoY) Softseed Processing & Refining : $255M (+1721% YoY) Grain Merchandising & Milling : $67M (+131% YoY) Tropical Oils & Specialty : $29M (+11.5% YoY) Total Adj. Segment EBIT : $796M (+113.4% YoY) ===================================================
Competitor & Sector Dynamics
- Archer-Daniels-Midland (ADM): Benefiting from Midwest farmer grain sales following a crude oil-driven crop price rally. However, ADM faces similar margin compression in grain merchandising as regional crop price spreads narrow.
- Biofuel Feedstock Tailwinds: Strong U.S. Environmental Protection Agency (EPA) mandates for renewable diesel are supporting domestic soybean oil pricing, giving Bunge a structural advantage over non-integrated processors.
Bull Case vs. Bear Case
Bull Case
- Viterra Synergy Upside: Synergies tracking well ahead of plan ($350M target) will drive structural margin expansion into FY2027.
- Unrivaled Global Network: Integrated origin-to-destination platform allows Bunge to capture arbitrage opportunities during geopolitical trade disruptions.
- Discounted Valuation: Trading at ~11.5x FY2026 EPS guidance midpoint ($9.50), well below historical peers when adjusted for combined Viterra earnings capacity.
- Bioenergy Demand: Strategic partnerships (e.g., Mubadala’s Acelen in Brazil) lock in long-term soybean oil feedstock demand.
Bear Case
- Working Capital & Cash Flow Drag: Negative operating cash flow (-$1.13B in 1H 2026) strains balance sheet liquidity and limits near-term share buybacks post-completion of the initial $2B program.
- Glencore Equity Overhang: Expiration of Glencore's share lockup could trigger block sales, capping near-term upside.
- Elevated Debt Service: $15.2B total debt and >$620M annual interest expense diminish net margin safety buffers in a low-commodity-price regime.
5. TECHNICAL SNAPSHOT
- Key Support Levels: $105.00 (psychological & horizontal support), $100.00 (major psychological floor), $98.50 (200-day Simple Moving Average line).
- Key Resistance Levels: $115.00 (pre-market breakdown gap), $117.50 (pre-earnings closing level), $125.00 (recent high resistance).
- Volume Analysis: Heavy institutional capitulation volume on July 29, 2026. Trading volume spiked significantly above the 90-day daily average of ~2.0 million shares, indicating widespread portfolio re-balancing following the print.
- Chart Patterns: Gap-down earnings breakdown. The stock sliced cleanly below its 50-day moving average (~$116.20), breaking the lower boundary of an ascending channel that had been intact since Q1 2026. Daily Relative Strength Index (RSI) dropped toward 34, nearing oversold territory.
6. RISK FACTORS
- Working Capital Liquidity Trap: Failure to monetize the $15.46 billion inventory stockpile in H2 2026 could prolong negative free cash flow and force additional short-term debt issuance.
- Secondary Market Supply Overhang: Potential institutional liquidations by Glencore following lockup expiration.
- Commodity Crush Margin Normalization: Global oilseed crushing capacity additions in South America and North America could compress crush spreads in late 2026 / early 2027.
- Policy & Biofuel Regulatory Shifts: Any changes to Renewable Volume Obligations (RVOs) or Small Refinery Exemptions (SREs) by regulatory bodies could alter vegetable oil demand dynamics.
7. ACTIONABLE OUTLOOK
+-----------------------------------------------------------------------+ | OUTLOOK TIMEHORIZON | TARGET / PRICE RANGE | CONVICTION & THESIS | +-----------------------------------------------------------------------+ | Short-Term (1-2 Wks) | $104.00 – $110.00 | NEUTRAL / CONSOLIDATION| | Medium-Term (1-3 Mos) | $115.00 – $122.00 | MODERATELY BULLISH | | Long-Term (12+ Mos) | $135.00 – $145.00 | BULLISH | +-----------------------------------------------------------------------+
Short-Term (1–2 Weeks): Neutral / Consolidation
Expect choppy range-bound trading between $104.00 and $110.00. The stock is technically oversold following the single-day 8.17% drop. Tax-lot selling and lockup concerns will likely cap near-term bounces at the $112.00–$115.00 resistance gap.
Medium-Term (1–3 Months): Moderately Bullish
As Bunge converts its H1 inventory build into cash flow during the H2 harvest season, operating cash flow will normalize back into positive territory. Demonstration of $350 million in Viterra synergies should catalyze a re-test of $115.00–$122.00.
Long-Term Thesis: Bullish (Fundamentally Intact)
Bunge’s core thesis as the global leader in agribusiness infrastructure remains fully intact. Post-Viterra, Bunge possesses unmatched global sourcing and processing capacity. At ~11.5x FY2026 EPS with an authorized $3.0 billion share repurchase plan and a 2.67% dividend yield ($2.88/share), current price levels represent an attractive entry point for institutional value investors looking past short-term working capital noise.